What are the major opportunities in the Genitourinary Drugs market? What are the strategies for the Genitourinary Drugs market?

For detailed insights on the major opportunities and strategies in the Genitourinary Drugs market, Read More

How does the Genitourinary Drugs market relate to the overall economy and other similar markets?

For detailed insights on Genitourinary Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Genitourinary Drugs market growth? SWOT analysis of the Genitourinary Drugs market.

For detailed insights on the key dynamics influencing the Genitourinary Drugs market growth and SWOT analysis of the Genitourinary Drugs industry, Read More

Global Genitourinary Drugs Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Genitourinary Drugs Global Market Report 2025

Name: Genitourinary Drugs Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Urologicals, Hormonal Therapy, Gynecological, Anti-Infectives, Other Products), By Route Of Administration (Oral, Parenteral, Topical), By Application (Urinary Tract Infections (UTIs), Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Overactive Bladder, Bladder Cancer, Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Genitourinary Drugs Market?

Genitourinary drugs are medications used to treat conditions affecting the urinary and reproductive organs, including the kidneys, bladder, urethra, and genital organs. Their main purpose is to manage infections, control overactive bladder, treat erectile dysfunction, relieve urinary pain, or regulate hormonal functions. These drugs help restore normal genitourinary function and improve patient quality of life.

The main product types of genitourinary drugs include urologicals, hormonal therapy, gynecological, anti-infectives, and others. Urologicals refer to pharmaceutical drugs used for the treatment of disorders affecting the urinary tract and male reproductive organs. These are administered through various routes, such as oral, parenteral, and topical methods, catering to a range of applications such as urinary tract infections (UTIs), benign prostatic hyperplasia (BPH), prostate cancer, overactive bladder, bladder cancer, and others. Genitourinary drugs are distributed through various channels, including hospital pharmacies, drugstore and retail pharmacies, and online pharmacies.

Genitourinary Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Genitourinary Drugs Market Size 2025 And Growth Rate?

The genitourinary drugs market size has grown steadily in recent years. It will grow from $30.07 billion in 2024 to $31.02 billion in 2025 at a compound annual growth rate (CAGR) of 3.2%. The growth in the historic period can be attributed to increasing prevalence of urinary tract infections, rising cases of benign prostatic hyperplasia, growing awareness of sexual health, rising aging population, and rising incidence of chronic kidney diseases.

What Is The Genitourinary Drugs Market Growth Forecast?

The genitourinary drugs market size is expected to see steady growth in the next few years. It will grow to $34.76 billion in 2029 at a compound annual growth rate (CAGR) of 2.9%. The growth in the forecast period can be attributed to increasing prevalence of urinary tract infections, growing awareness of sexual health, expanding healthcare infrastructure, increasing demand for hormone replacement therapies, and growing use of oral contraceptives. Major trends in the forecast period include advancements in drug formulations and delivery systems, integration of digital health solutions, technology-driven personalized medicine approaches, developments in biologic therapies, and advancements in precision medicine.

Book your 30 minutes free consultation with our research experts

How Is The Genitourinary Drugs Market Segmented?

The genitourinary drugs market covered in this report is segmented –

1) By Product: Urologicals, Hormonal Therapy, Gynecological, Anti-Infectives, Other Products

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Application: Urinary Tract Infections (UTIs), Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Overactive Bladder, Bladder Cancer, Other Applications

4) By Distribution Channel: Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Urologicals: Benign Prostatic Hyperplasia (BPH) Drugs, Urinary Incontinence Drugs, Overactive Bladder (OAB) Drugs, Urolithiasis (Kidney Stone) Drugs, Erectile Dysfunction Drugs

2) By Hormonal Therapy: Estrogen Therapy, Progestin Therapy, Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists, Androgen Replacement Therapy, Selective Estrogen Receptor Modulators (SERMs)

3) By Gynecological: Contraceptives, Menopausal Hormone Therapy, fertility drugs, Drugs for Endometriosis, Drugs for Polycystic Ovary Syndrome (PCOS)

4) By Anti-Infectives: Urinary Tract Infection (UTI) Drugs, Sexually Transmitted Infection (STI) Drugs, Vaginal Antifungals, Antivirals

5) By Other Products: Drugs for Chronic Pelvic Pain, Bladder Cancer Therapies, Interstitial Cystitis Drugs, Pelvic Organ Prolapse Treatment Drugs, Adjunctive Therapies

What Is Driving The Genitourinary Drugs Market? Growing Prevalence Of Genitourinary Disorders Fueling The Growth Of The Market Due To Rising Aging Population And Cancer Burden

The growing prevalence of genitourinary disorders is expected to propel the growth of the genitourinary drugs market going forward. Genitourinary disorders are medical conditions that affect the genitourinary system, which comprises both the urinary and reproductive organs, including infections, cancers, and functional or structural issues. The growing prevalence of genitourinary disorders is due to the aging population, as age-related changes increase the risk of urinary and reproductive health conditions. Genitourinary drugs help manage genitourinary disorders by targeting urinary and reproductive system conditions, offering relief from infections, inflammation, and dysfunction. They improve patient outcomes by enabling effective, convenient, and condition-specific treatment, enhancing overall quality of life. For instance, in April 2024, according to the report by the American Cancer Society, a US-based non-profit organization, approximately 20 million new cancer cases were diagnosed globally in 2022, with 9.7 million deaths, and the number of cancer cases is projected to rise to 35 million by 2050. Therefore, the growing prevalence of genitourinary disorders is driving the growth of the genitourinary drugs market.

Who Are The Major Players In The Global Genitourinary Drugs Market?

Major companies operating in the genitourinary drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Abbott Laboratories, GSK plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Ipsen Société Anonyme, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals Public Limited Company, Zydus Lifesciences Limited, Endo International Public Limited Company, Takeda Pharmaceutical Company Limited, Zydus Lifesciences Limited, Melinta Therapeutics Inc., Asieris Pharmaceuticals, Sun Pharmaceutical Industries Ltd.

What Are The Key Trends Of The Global Genitourinary Drugs Market? First-In-Class Oral Therapy Approved For Adolescent And Adult UTI Care

Major companies operating in the genitourinary drugs market are focusing on developing innovative products, such as oral antibiotics, to enhance treatment convenience, improve patient adherence, and combat infections effectively. Oral antibiotics refer to antibacterial medications taken by mouth to treat infections caused by bacteria. For instance, in March 2025, GSK plc, a UK-based pharmaceutical company, received approval from the US Food and Drug Administration (FDA) for Blujepa (gepotidacin) for treating uncomplicated urinary tract infections caused by susceptible bacteria in women and girls aged 12 and older. It is a novel, first-in-class oral antibiotic that works by inhibiting bacterial DNA replication, targeting two critical enzymes, namely DNA gyrase and topoisomerase IV. Unlike traditional antibiotics, it binds to unique sites to overcome resistance, offering a targeted mechanism with improved safety and efficacy.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Genitourinary Drugs Market? Pfizer Acquires Seagen To Boost Cancer Drug Portfolio

In December 2023, Pfizer Inc., a US-based pharmaceutical company, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to transform cancer treatment by integrating antibody-drug conjugate (ADC) technology with its global scale and expertise. Seagen Inc. is a US-based biotechnology company specializing in innovative genitourinary cancer drugs, notably Padcev for advanced bladder cancer.

What Is The Regional Outlook For The Global Genitourinary Drugs Market?

North America was the largest region in the genitourinary drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genitourinary drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genitourinary drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genitourinary Drugs Market?

The genitourinary drugs market consists of sales of urinary acidifiers and alkalinizers, desmopressin, diuretics, urinary antispasmodics, anti-infectives, and hormone replacement therapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Genitourinary Drugs Industry?

The genitourinary drugs market research report is one of a series of new reports from The Business Research Company that provides genitourinary drugs market statistics, including the genitourinary drugs industry global market size, regional shares, competitors with the genitourinary drugs market share, detailed genitourinary drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the genitourinary drugs industry. This genitourinary drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Genitourinary Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$31.02 billion
Revenue Forecast In 2034	$34.76 billion
Growth Rate	CAGR of 2.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The genitourinary drugs market covered in this report is segmented – 1) By Product: Urologicals, Hormonal Therapy, Gynecological, Anti-Infectives, Other Products 2) By Route Of Administration: Oral, Parenteral, Topical 3) By Application: Urinary Tract Infections (UTIs), Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Overactive Bladder, Bladder Cancer, Other Applications 4) By Distribution Channel: Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies Subsegments: 1) By Urologicals: Benign Prostatic Hyperplasia (BPH) Drugs, Urinary Incontinence Drugs, Overactive Bladder (OAB) Drugs, Urolithiasis (Kidney Stone) Drugs, Erectile Dysfunction Drugs 2) By Hormonal Therapy: Estrogen Therapy, Progestin Therapy, Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists, Androgen Replacement Therapy, Selective Estrogen Receptor Modulators (SERMs) 3) By Gynecological: Contraceptives, Menopausal Hormone Therapy, Fertility Drugs, Drugs for Endometriosis, Drugs for Polycystic Ovary Syndrome (PCOS) 4) By Anti-Infectives: Urinary Tract Infection (UTI) Drugs, Sexually Transmitted Infection (STI) Drugs, Vaginal Antifungals, Antivirals 5) By Other Products: Drugs for Chronic Pelvic Pain, Bladder Cancer Therapies, Interstitial Cystitis Drugs, Pelvic Organ Prolapse Treatment Drugs, Adjunctive Therapies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Abbott Laboratories, GSK plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Ipsen Société Anonyme, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals Public Limited Company, Zydus Lifesciences Limited, Endo International Public Limited Company, Takeda Pharmaceutical Company Limited, Zydus Lifesciences Limited, Melinta Therapeutics Inc., Asieris Pharmaceuticals, Sun Pharmaceutical Industries Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Genitourinary Drugs Market Characteristics

3. Genitourinary Drugs Market Trends And Strategies

4. Genitourinary Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genitourinary Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Genitourinary Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Genitourinary Drugs Market Growth Rate Analysis

5.4. Global Genitourinary Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Genitourinary Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Genitourinary Drugs Total Addressable Market (TAM)

6. Genitourinary Drugs Market Segmentation

6.1. Global Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urologicals

Hormonal Therapy

Gynecological

Anti-Infectives

Other Products

6.2. Global Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Topical

6.3. Global Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urinary Tract Infections (Utis)

Benign Prostatic Hyperplasia (BPH)

Prostate Cancer

Overactive Bladder

Bladder Cancer

Other Applications

6.4. Global Genitourinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Drug Store And Retail Pharmacies

Online Pharmacies

6.5. Global Genitourinary Drugs Market, Sub-Segmentation Of Urologicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Benign Prostatic Hyperplasia (BPH) Drugs

Urinary Incontinence Drugs

Overactive Bladder (OAB) Drugs

Urolithiasis Drugs

Erectile Dysfunction Drugs

6.6. Global Genitourinary Drugs Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Estrogen Therapy

Progestin Therapy

Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists

Androgen Replacement Therapy

Selective Estrogen Receptor Modulators (SERMs)

6.7. Global Genitourinary Drugs Market, Sub-Segmentation Of Gynecological, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Contraceptives

Menopausal Hormone Therapy

Fertility Drugs

Drugs For Endometriosis

Drugs For Polycystic Ovary Syndrome (PCOS)

6.8. Global Genitourinary Drugs Market, Sub-Segmentation Of Anti-Infectives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urinary Tract Infection (UTI) Drugs

Sexually Transmitted Infection (STI) Drugs

Vaginal Antifungals

Antivirals

6.9. Global Genitourinary Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drugs For Chronic Pelvic Pain

Bladder Cancer Therapies

Interstitial Cystitis Drugs

Pelvic Organ Prolapse Treatment Drugs

Adjunctive Therapies

7. Genitourinary Drugs Market Regional And Country Analysis

7.1. Global Genitourinary Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Genitourinary Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genitourinary Drugs Market

8.1. Asia-Pacific Genitourinary Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genitourinary Drugs Market

9.1. China Genitourinary Drugs Market Overview

9.2. China Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genitourinary Drugs Market

10.1. India Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genitourinary Drugs Market

11.1. Japan Genitourinary Drugs Market Overview

11.2. Japan Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genitourinary Drugs Market

12.1. Australia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genitourinary Drugs Market

13.1. Indonesia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genitourinary Drugs Market

14.1. South Korea Genitourinary Drugs Market Overview

14.2. South Korea Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genitourinary Drugs Market

15.1. Western Europe Genitourinary Drugs Market Overview

15.2. Western Europe Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genitourinary Drugs Market

16.1. UK Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genitourinary Drugs Market

17.1. Germany Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genitourinary Drugs Market

18.1. France Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genitourinary Drugs Market

19.1. Italy Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genitourinary Drugs Market

20.1. Spain Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genitourinary Drugs Market

21.1. Eastern Europe Genitourinary Drugs Market Overview

21.2. Eastern Europe Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genitourinary Drugs Market

22.1. Russia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genitourinary Drugs Market

23.1. North America Genitourinary Drugs Market Overview

23.2. North America Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genitourinary Drugs Market

24.1. USA Genitourinary Drugs Market Overview

24.2. USA Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genitourinary Drugs Market

25.1. Canada Genitourinary Drugs Market Overview

25.2. Canada Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genitourinary Drugs Market

26.1. South America Genitourinary Drugs Market Overview

26.2. South America Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genitourinary Drugs Market

27.1. Brazil Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genitourinary Drugs Market

28.1. Middle East Genitourinary Drugs Market Overview

28.2. Middle East Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genitourinary Drugs Market

29.1. Africa Genitourinary Drugs Market Overview

29.2. Africa Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genitourinary Drugs Market Competitive Landscape And Company Profiles

30.1. Genitourinary Drugs Market Competitive Landscape

30.2. Genitourinary Drugs Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Genitourinary Drugs Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Sanofi S.A.

31.3. Bristol Myers Squibb

31.4. AstraZeneca plc

31.5. Abbott Laboratories

31.6. GSK plc

31.7. Eli Lilly and Company

31.8. Amgen Inc.

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Astellas Pharma Inc.

31.11. Ipsen Société Anonyme

31.12. Aurobindo Pharma Limited

31.13. Dr. Reddy's Laboratories Limited

31.14. Cipla Limited

31.15. Hikma Pharmaceuticals Public Limited Company

32. Global Genitourinary Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genitourinary Drugs Market

34. Recent Developments In The Genitourinary Drugs Market

35. Genitourinary Drugs Market High Potential Countries, Segments and Strategies

35.1 Genitourinary Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Genitourinary Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Genitourinary Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Genitourinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Genitourinary Drugs Market, Sub-Segmentation Of Urologicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Genitourinary Drugs Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Genitourinary Drugs Market, Sub-Segmentation Of Gynecological, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Genitourinary Drugs Market, Sub-Segmentation Of Anti-Infectives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Genitourinary Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Genitourinary Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Genitourinary Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Johnson & Johnson Financial Performance

Table 82: F. Hoffmann-La Roche AG Financial Performance

Table 83: Merck & Co. Inc. Financial Performance

Table 84: Bayer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Genitourinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Genitourinary Drugs Market, Sub-Segmentation Of Urologicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Genitourinary Drugs Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Genitourinary Drugs Market, Sub-Segmentation Of Gynecological, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Genitourinary Drugs Market, Sub-Segmentation Of Anti-Infectives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Genitourinary Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Genitourinary Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Genitourinary Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Johnson & Johnson Financial Performance

Figure 82: F. Hoffmann-La Roche AG Financial Performance

Figure 83: Merck & Co. Inc. Financial Performance

Figure 84: Bayer AG Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Pharmaceuticals Global Market Report 2022 – By Type (Pharmaceutical Drugs, Biologics), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, E-Commerce), By Nature (Organic, Conventional) – Market Size,...

Myelodysplastic Syndrome Drugs Global Market Report 2025 – By Therapeutic Class (Immunomodulatory Drugs, Hypomethylating Agents, Anti-anemics), By Type of Syndrome (Refractory Cytopenia With Multilineage Dysplasia, Refra...

Antiparasitic Drugs Global Market Report 2025 – By Product Type (Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products), By Treatment (Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazo...

Oral Transmucosal Drugs Global Market Report 2025 – By Product Type (Tablets, Films, Liquid And Spray, Other Product Types), By Indication (Opioid Dependence, Nausea And Vomiting, Erectile Dysfunction, Neurological Disor...

Generic Oncology Drugs Global Market Report 2025 – By Molecule Type (Large Molecule, Small Molecule), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pha...

Pharmaceutical Label Global Market Report 2025 – By Type (Pressure-Sensitive Label, Glue-Applied Label, Sleeve Label, In-Mold Label, Other Types), By Material (Paper, Polymer Film, Other Materials), By Application (Instr...

Frequently Asked Questions

What is the definition of the Genitourinary Drugs market?

How will the Genitourinary Drugs market drivers and restraints affect the market dynamics? What forces will shape the Genitourinary Drugs industry going forward?

The Genitourinary Drugs market major growth driver - Growing Prevalence Of Genitourinary Disorders Fueling The Growth Of The Market Due To Rising Aging Population And Cancer Burden. For further insights on the Genitourinary Drugs market, request a sample here

What is the forecast market size or the forecast market value of the Genitourinary Drugs market?

The Genitourinary Drugs market size has grown strongly in recent years. The genitourinary drugs market size has grown steadily in recent years. It will grow from $30.07 billion in 2024 to $31.02 billion in 2025 at a compound annual growth rate (CAGR) of 3.2%. The growth in the historic period can be attributed to increasing prevalence of urinary tract infections, rising cases of benign prostatic hyperplasia, growing awareness of sexual health, rising aging population, and rising incidence of chronic kidney diseases. The genitourinary drugs market size is expected to see steady growth in the next few years. It will grow to $34.76 billion in 2029 at a compound annual growth rate (CAGR) of 2.9%. The growth in the forecast period can be attributed to increasing prevalence of urinary tract infections, growing awareness of sexual health, expanding healthcare infrastructure, increasing demand for hormone replacement therapies, and growing use of oral contraceptives. Major trends in the forecast period include advancements in drug formulations and delivery systems, integration of digital health solutions, technology-driven personalized medicine approaches, developments in biologic therapies, and advancements in precision medicine. For further insights on the Genitourinary Drugs market, request a sample here

How is the Genitourinary Drugs market segmented?

The genitourinary drugs market covered in this report is segmented –
1) By Product: Urologicals, Hormonal Therapy, Gynecological, Anti-Infectives, Other Products
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Application: Urinary Tract Infections (UTIs), Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Overactive Bladder, Bladder Cancer, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Urologicals: Benign Prostatic Hyperplasia (BPH) Drugs, Urinary Incontinence Drugs, Overactive Bladder (OAB) Drugs, Urolithiasis (Kidney Stone) Drugs, Erectile Dysfunction Drugs
2) By Hormonal Therapy: Estrogen Therapy, Progestin Therapy, Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists, Androgen Replacement Therapy, Selective Estrogen Receptor Modulators (SERMs)
3) By Gynecological: Contraceptives, Menopausal Hormone Therapy, Fertility Drugs, Drugs for Endometriosis, Drugs for Polycystic Ovary Syndrome (PCOS)
4) By Anti-Infectives: Urinary Tract Infection (UTI) Drugs, Sexually Transmitted Infection (STI) Drugs, Vaginal Antifungals, Antivirals
5) By Other Products: Drugs for Chronic Pelvic Pain, Bladder Cancer Therapies, Interstitial Cystitis Drugs, Pelvic Organ Prolapse Treatment Drugs, Adjunctive Therapies For further insights on the Genitourinary Drugs market, request a sample here

Which region has the largest share of the Genitourinary Drugs market? What are the other regions covered in the report?

Who are the major players in the Genitourinary Drugs market?

What are the key trends in the Genitourinary Drugs market?

Major trends in the Genitourinary Drugs market include First-In-Class Oral Therapy Approved For Adolescent And Adult UTI Care. For further insights on the Genitourinary Drugs market, request a sample here.